Christopher C Riedl
Overview
Explore the profile of Christopher C Riedl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
1038
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Deipolyi A, Johnson C, Riedl C, Kunin H, Solomon S, Oklu R, et al.
Radiology
. 2022 Aug;
306(1):279-287.
PMID: 35972356
Background The impact of transarterial radioembolization (TARE) of breast cancer liver metastasis (BCLM) on antitumor immunity is unknown, which hinders the optimal selection of candidates for TARE. Purpose To determine...
2.
Das J, Bou-Ayache J, Gollub M, Riedl C, Ulaner G
World J Nucl Med
. 2021 Jul;
20(2):208-210.
PMID: 34321979
A 75-year-old woman presented with a 1-month history of abdominal pain. Contrast-enhanced computed tomography (CT) demonstrated a large solid mass in the left lower abdominal quadrant, suspicious for malignancy. Staging...
3.
Young R, Demetrio de Souza Franca P, Pirovano G, Piotrowski A, Nicklin P, Riedl C, et al.
Neurooncol Adv
. 2021 Jan;
2(1):vdaa119.
PMID: 33392502
Background: We report preclinical and first-in-human-brain-cancer data using a targeted poly (ADP-ribose) polymerase 1 (PARP1) binding PET tracer, [F]PARPi, as a diagnostic tool to differentiate between brain cancers and treatment-related...
4.
Bitencourt A, Rossi Saccarelli C, Morris E, Flynn J, Zhang Z, Khan A, et al.
JAMA Netw Open
. 2020 Oct;
3(10):e2018790.
PMID: 33034638
Importance: Regional nodal irradiation (RNI) for node-positive breast cancer reduces distant metastases and improves survival, albeit with limited reduction in regional nodal recurrences. The mechanism by which RNI robustly reduces...
5.
Das J, Riedl C, Ulaner G
Clin Nucl Med
. 2020 Sep;
45(12):989-991.
PMID: 32956122
A 21-year-old man with NF1 (neurofibromatosis type 1) mutation and in remission from acute myeloid leukemia presented with a painless mass in the left upper limb. MRI showed a soft-tissue...
6.
Ulaner G, Jhaveri K, Chandarlapaty S, Hatzoglou V, Riedl C, Lewis J, et al.
J Nucl Med
. 2020 Jul;
62(3):326-331.
PMID: 32680923
Invasive lobular carcinoma (ILC) demonstrates lower conspicuity on F-FDG PET than the more common invasive ductal carcinoma. Other molecular imaging methods may be needed for evaluation of this malignancy. As...
7.
Ulaner G, Carrasquillo J, Riedl C, Yeh R, Hatzoglou V, Ross D, et al.
Radiology
. 2020 Jun;
296(2):370-378.
PMID: 32515679
Background Human epidermal growth factor receptor 2 (HER2)-targeted therapies are successful in patients with HER2-positive malignancies; however, spatial and temporal heterogeneity of HER2 expression may prevent identification of optimal patients...
8.
Mayerhoefer M, Riedl C, Kumar A, Dogan A, Gibbs P, Weber M, et al.
Cancers (Basel)
. 2020 May;
12(5).
PMID: 32370121
Biopsy is the standard for assessment of bone marrow involvement in mantle cell lymphoma (MCL). We investigated whether [18F]FDG-PET radiomic texture features can improve prediction of bone marrow involvement in...
9.
Ulaner G, Sobol N, ODonoghue J, Kirov A, Riedl C, Min R, et al.
Radiology
. 2020 Apr;
295(3):606-615.
PMID: 32255416
Background Current measurements of multiple myeloma disease burden are suboptimal. Daratumumab is a monoclonal antibody that targets CD38, an antigen expressed on nearly all myeloma cells. Purpose To demonstrate preclinical...
10.
Marino M, Avendano D, Zapata P, Riedl C, Pinker K
Oncologist
. 2020 Feb;
25(2):e231-e242.
PMID: 32043792
The detection of lymph node metastasis affects the management of patients with primary breast cancer significantly in terms of staging, treatment, and prognosis. The main goal for the radiologist is...